ID

39577

Descrizione

Boceprevir in End Stage Renal Disease (ESRD); ODM derived from: https://clinicaltrials.gov/show/NCT02112630

collegamento

https://clinicaltrials.gov/show/NCT02112630

Keywords

versioni (1)
  1. 31/01/20 31/01/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

31 gennaio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C Infection NCT02112630

Inglese

Eligibility Hepatitis C Infection NCT02112630

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. adult (ages 18-75)
Descrizione

Adult | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
2. hepatitis c virus ribonucleic acid (hcv rna) 1000 iu/ml or greater
Descrizione

Hepatitis C virus RNA assay

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1272251
3. hepatitis c virus (hcv) genotype 1
Descrizione

Hepatitis C virus genotype determination

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1533728
4. end stage renal disease on hemodialysis
Descrizione

Kidney Failure, Chronic | Hemodialysis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0019004
5. females of child bearing potential must be using an adequate method of contraception throughout the study and must have a negative pregnancy test prior to the start of treatment.
Descrizione

Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy test negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0427780
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. intolerance to peg-ifn or ribavirin with prior treatment course.
Descrizione

Intolerance to PEGINTERFERON | Intolerance to Ribavirin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0982327
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0035525
2. prior treatment with protease inhibitor (telaprevir or boceprevir) or experimental protease inhibitor
Descrizione

Protease Inhibitors | telaprevir | boceprevir | Protease Inhibitors Investigational

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0033607
UMLS CUI [2]
C1876229
UMLS CUI [3]
C1738934
UMLS CUI [4,1]
C0033607
UMLS CUI [4,2]
C1517586
3. significant cytopenias:
Descrizione

Cytopenia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0010828
1. absolute neutrophil count (anc) < 1000/mm3, or
Descrizione

Absolute neutrophil count

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0948762
2. hemoglobin (hgb) <10.5 g/dl, or
Descrizione

Hemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0518015
3. platelet count < 50,000/mm3
Descrizione

Platelet Count measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032181
4. significant laboratory abnormalities
Descrizione

Laboratory test result abnormal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0438215
1. direct bilirubin > 1.5 x upper limit of normal (uln)
Descrizione

Direct bilirubin increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0740434
2. total bilirubin > 1.6 mg/dl unless due to gilbert's disease
Descrizione

Serum total bilirubin measurement | Exception Due to Gilbert Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0017551
3. prothrombin time (pt)/partial thromboplastin time (ptt) > 10% above laboratory reference range
Descrizione

Prothrombin time increased | Partial thromboplastin time increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151872
UMLS CUI [2]
C0240671
4. thyroid stimulating hormone (tsh) > 1.2 x uln or < 0.8 x lower limit of normal (lln)
Descrizione

Raised TSH level | Decreased thyroid stimulating hormone level

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0586553
UMLS CUI [2]
C1295607
5. uncontrolled depression or psychiatric disease
Descrizione

Depressive disorder Uncontrolled | Mental disorder Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011581
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0205318
6. uncontrolled cardiopulmonary or cardiovascular disease
Descrizione

Cor pulmonale Uncontrolled | Cardiovascular Disease Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0034072
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205318
7. autoimmune diseases except for treated thyroid disease
Descrizione

Autoimmune Diseases | Exception Thyroid Disease Treated

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0040128
UMLS CUI [2,3]
C1522326
8. active substance abuse within 6 months of initiation of treatment
Descrizione

Substance Use Disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038586
9. recent (within 4 weeks) episode of infection requiring systemic antibiotics
Descrizione

Episode of Communicable Disease Recent | Requirement Antibiotics for systemic use

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332189
UMLS CUI [1,2]
C0009450
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C3540704
10. any medical condition that would be predicted to be exacerbated by therapy or that would limit study participation
Descrizione

Medical condition Exacerbation Due to Therapy | Medical condition Limiting Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C4086268
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0087111
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C2348568
11. any medical condition requiring or likely to require chronic systemic administration of corticosteroids or other immunosuppressive medications during the course of this study
Descrizione

Medical condition Requirement CORTICOSTEROIDS FOR SYSTEMIC USE chronic | Medical condition Requirement Immunosuppressive Agents

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C3653708
UMLS CUI [1,4]
C0205191
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0021081
12. human immunodeficiency virus (hiv) or hepatitis b virus (hbv) co-infection
Descrizione

HIV coinfection | HBV coinfection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C2242656
13. hepatocellular carcinoma (hcc) (patients with hcc who are listed for liver transplantation may be included.)
Descrizione

Liver carcinoma | Exception Patient on waiting list Transplantation of liver

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0422768
UMLS CUI [2,3]
C0023911
14. other significant chronic liver disease diagnosis
Descrizione

Chronic liver disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0341439
15. evidence of decompensated liver disease
Descrizione

Decompensated liver disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4075847
16. solid organ transplant recipient (patients who have a history of renal transplant, and have experienced kidney graft loss, and are not on immunosuppression may be included.)
Descrizione

Solid organ transplant Recipient

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0730400
UMLS CUI [1,2]
C1709854
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis C Infection NCT02112630

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
1. adult (ages 18-75)
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Hepatitis C virus RNA assay
Item
2. hepatitis c virus ribonucleic acid (hcv rna) 1000 iu/ml or greater
boolean
C1272251 (UMLS CUI [1])
Hepatitis C virus genotype determination
Item
3. hepatitis c virus (hcv) genotype 1
boolean
C1533728 (UMLS CUI [1])
Kidney Failure, Chronic | Hemodialysis
Item
4. end stage renal disease on hemodialysis
boolean
C0022661 (UMLS CUI [1])
C0019004 (UMLS CUI [2])
Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy test negative
Item
5. females of child bearing potential must be using an adequate method of contraception throughout the study and must have a negative pregnancy test prior to the start of treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0427780 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Intolerance to PEGINTERFERON | Intolerance to Ribavirin
Item
1. intolerance to peg-ifn or ribavirin with prior treatment course.
boolean
C1744706 (UMLS CUI [1,1])
C0982327 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Protease Inhibitors | telaprevir | boceprevir | Protease Inhibitors Investigational
Item
2. prior treatment with protease inhibitor (telaprevir or boceprevir) or experimental protease inhibitor
boolean
C0033607 (UMLS CUI [1])
C1876229 (UMLS CUI [2])
C1738934 (UMLS CUI [3])
C0033607 (UMLS CUI [4,1])
C1517586 (UMLS CUI [4,2])
Cytopenia
Item
3. significant cytopenias:
boolean
C0010828 (UMLS CUI [1])
Absolute neutrophil count
Item
1. absolute neutrophil count (anc) < 1000/mm3, or
boolean
C0948762 (UMLS CUI [1])
Hemoglobin measurement
Item
2. hemoglobin (hgb) <10.5 g/dl, or
boolean
C0518015 (UMLS CUI [1])
Platelet Count measurement
Item
3. platelet count < 50,000/mm3
boolean
C0032181 (UMLS CUI [1])
Laboratory test result abnormal
Item
4. significant laboratory abnormalities
boolean
C0438215 (UMLS CUI [1])
Direct bilirubin increased
Item
1. direct bilirubin > 1.5 x upper limit of normal (uln)
boolean
C0740434 (UMLS CUI [1])
Serum total bilirubin measurement | Exception Due to Gilbert Disease
Item
2. total bilirubin > 1.6 mg/dl unless due to gilbert's disease
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0017551 (UMLS CUI [2,3])
Prothrombin time increased | Partial thromboplastin time increased
Item
3. prothrombin time (pt)/partial thromboplastin time (ptt) > 10% above laboratory reference range
boolean
C0151872 (UMLS CUI [1])
C0240671 (UMLS CUI [2])
Raised TSH level | Decreased thyroid stimulating hormone level
Item
4. thyroid stimulating hormone (tsh) > 1.2 x uln or < 0.8 x lower limit of normal (lln)
boolean
C0586553 (UMLS CUI [1])
C1295607 (UMLS CUI [2])
Depressive disorder Uncontrolled | Mental disorder Uncontrolled
Item
5. uncontrolled depression or psychiatric disease
boolean
C0011581 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Cor pulmonale Uncontrolled | Cardiovascular Disease Uncontrolled
Item
6. uncontrolled cardiopulmonary or cardiovascular disease
boolean
C0034072 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Autoimmune Diseases | Exception Thyroid Disease Treated
Item
7. autoimmune diseases except for treated thyroid disease
boolean
C0004364 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0040128 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
Substance Use Disorder
Item
8. active substance abuse within 6 months of initiation of treatment
boolean
C0038586 (UMLS CUI [1])
Episode of Communicable Disease Recent | Requirement Antibiotics for systemic use
Item
9. recent (within 4 weeks) episode of infection requiring systemic antibiotics
boolean
C0332189 (UMLS CUI [1,1])
C0009450 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C1514873 (UMLS CUI [2,1])
C3540704 (UMLS CUI [2,2])
Medical condition Exacerbation Due to Therapy | Medical condition Limiting Study Subject Participation Status
Item
10. any medical condition that would be predicted to be exacerbated by therapy or that would limit study participation
boolean
C3843040 (UMLS CUI [1,1])
C4086268 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
Medical condition Requirement CORTICOSTEROIDS FOR SYSTEMIC USE chronic | Medical condition Requirement Immunosuppressive Agents
Item
11. any medical condition requiring or likely to require chronic systemic administration of corticosteroids or other immunosuppressive medications during the course of this study
boolean
C3843040 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C3653708 (UMLS CUI [1,3])
C0205191 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0021081 (UMLS CUI [2,3])
HIV coinfection | HBV coinfection
Item
12. human immunodeficiency virus (hiv) or hepatitis b virus (hbv) co-infection
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Liver carcinoma | Exception Patient on waiting list Transplantation of liver
Item
13. hepatocellular carcinoma (hcc) (patients with hcc who are listed for liver transplantation may be included.)
boolean
C2239176 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0422768 (UMLS CUI [2,2])
C0023911 (UMLS CUI [2,3])
Chronic liver disease
Item
14. other significant chronic liver disease diagnosis
boolean
C0341439 (UMLS CUI [1])
Decompensated liver disease
Item
15. evidence of decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Solid organ transplant Recipient
Item
16. solid organ transplant recipient (patients who have a history of renal transplant, and have experienced kidney graft loss, and are not on immunosuppression may be included.)
boolean
C0730400 (UMLS CUI [1,1])
C1709854 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial